Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The company said that the nasal spray is a ketamine-derived drug, first approved in 2019, to be used in combination with ...

signaling a potential new era in depression treatment. So, how is the global antidepressants market segmented? The market can be segmented by: 1 Product: Selective Serotonin Reuptake Inhibitor ...

As the global economy recovers in 2021 and the supply of the industrial chain improves, the Antidepressant Medication market will undergo major changes. The latest research shows that the ...

They suggest other fast-acting antidepressants could offer a competitive challenge to J&J's drug, including Axsome Therapeutics' recently approved Auvelity (bupropion/dextromethorphan), Sage ...

Mizuho Securities analyst Graig Suvannavejh has reiterated their bullish stance on AXSM stock, giving a Buy rating on January 15.Stay Ahead of ...

New York, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Overview: The Antidepressant Drugs Market size is expected to reach USD 20.1 billion by 2024 and is further anticipated to reach USD 26.9 billion by 2033 ...

Alembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in ...

A recent study revealed that making antidepressants that exclusively interact ... s Vagelos College of Physicians and Surgeons in New York City, in a press release. The study findings further ...

Alembic Pharmaceuticals has received USFDA approval for its generic version of Brexpiprazole tablets, used to treat major ...